These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36418859)

  • 1. Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2/twist-VE-cadherin/AKT pathway in human prostate cancer PC-3 cells.
    Han DS; Lee HJ; Lee EO
    Sci Rep; 2022 Nov; 12(1):20125. PubMed ID: 36418859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells.
    Yeo C; Lee HJ; Lee EO
    Life Sci; 2019 Mar; 221():267-273. PubMed ID: 30797819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.
    Yeo C; Han DS; Lee HJ; Lee EO
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sp1 Plays a Key Role in Vasculogenic Mimicry of Human Prostate Cancer Cells.
    Han DS; Lee EO
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
    World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin Promotes Vasculogenic Mimicry in Breast Cancer Cells by Regulating Aquaporin-1.
    Han DS; Lee EO
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual VEGF/PDGF knockdown suppresses vasculogenic mimicry formation in choroidal melanoma cells via the Wnt5a/β-catenin/AKT signaling pathway.
    Yuan Y; Geng B; Xu X; Zhao H; Bai J; Dou Z; Jia S; Yu X; Luo W
    Acta Histochem; 2022 Jan; 124(1):151842. PubMed ID: 34995928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway.
    Hsu JL; Leu WJ; Hsu LC; Hsieh CH; Guh JH
    Oncol Lett; 2024 Apr; 27(4):170. PubMed ID: 38455663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression.
    Guo JQ; Zheng QH; Chen H; Chen L; Xu JB; Chen MY; Lu D; Wang ZH; Tong HF; Lin S
    Int J Oncol; 2014 Sep; 45(3):1065-72. PubMed ID: 24938458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
    Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
    Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
    Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
    J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry.
    Hess AR; Seftor EA; Seftor RE; Hendrix MJ
    Cancer Res; 2003 Aug; 63(16):4757-62. PubMed ID: 12941789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of WT1 isoforms in vasculogenic mimicry and metastatic potential of human triple negative breast cancer cells.
    Bissanum R; Lirdprapamongkol K; Svasti J; Navakanitworakul R; Kanokwiroon K
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):256-262. PubMed ID: 29024629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.
    Hess AR; Seftor EA; Gruman LM; Kinch MS; Seftor RE; Hendrix MJ
    Cancer Biol Ther; 2006 Feb; 5(2):228-33. PubMed ID: 16481735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway.
    Cheng R; Wang B; Cai XR; Chen ZS; Du Q; Zhou LY; Ye JM; Chen YL
    Onco Targets Ther; 2020; 13():11485-11498. PubMed ID: 33204103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupeol and Paclitaxel cooperate in hindering hypoxia induced vasculogenic mimicry via suppression of HIF-1α-EphA2-Laminin-5γ2 network in human oral cancer.
    Saha D; Mitra D; Alam N; Sen S; Mustafi SM; Majumder PK; Majumder B; Murmu N
    J Cell Commun Signal; 2023 Sep; 17(3):591-608. PubMed ID: 36063341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
    Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
    Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
    Wang HF; Wang SS; Zheng M; Dai LL; Wang K; Gao XL; Cao MX; Yu XH; Pang X; Zhang M; Wu JB; Wu JS; Yang X; Tang YJ; Chen Y; Tang YL; Liang XH
    Cell Prolif; 2019 May; 52(3):e12600. PubMed ID: 30945361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
    Han H; Du L; Cao Z; Zhang B; Zhou Q
    Eur J Pharmacol; 2018 Jan; 818():593-603. PubMed ID: 29162433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.